Since APOC3 silencing reduced blood glucose, and improved glycemia is associated with improved kidney disease, we tested the effect of APOC3 silencing in a model in which APOC3 ASO does not reduce blood glucose (9). This evidence concerns the gene APOC3 and kidney disorder.